Published online September 24, 2007
doi:10.1084/jem.20070404
The Journal of Experimental Medicine, Vol. 204, No. 10, 2439-2448
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Kerschen et al.
Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C
Edward J. Kerschen1,
José A. Fernandez2,
Brian C. Cooley4,
Xia V. Yang2,
Rashmi Sood1,
Laurent O. Mosnier2,
Francis J. Castellino5,
Nigel Mackman3,
John H. Griffin2, and
Hartmut Weiler1
1 Blood Research Institute, Milwaukee, WI 53226
2 Molecular and Experimental Medicine Department and 3 Immunology Department, The Scripps Research Institute, La Jolla, CA 92037
4 Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI 53226
5 Chemistry Department, University of Notre Dame, Notre Dame, IN 56556
CORRESPONDENCE Hartmut Weiler: hartmut.weiler{at}bcw.edu
Activated protein C (APC) reduces mortality of severe sepsis patients but increases the risk of serious bleeding. APC exerts anticoagulant activity by proteolysis of factors Va/VIIIa. APC also exerts antiinflammatory and antiapoptotic effects and stabilizes endothelial barrier function by APC-initiated cell signaling that requires two receptors, endothelial cell protein C receptor (EPCR) and protease-activated receptor 1 (PAR1). The relative importance of APC's various activities for efficacy in sepsis is unknown. We used protein engineering of mouse APC and genetically altered mice to clarify mechanisms for the efficacy of APC in mouse sepsis models. Mortality reduction in LPS-induced endotoxemia required the enzymatic active site of APC, EPCR, and PAR-1, highlighting a key role for APC's cytoprotective actions. A recombinant APC variant with normal signaling but <10% anticoagulant activity (5A-APC) was as effective as wild-type APC in reducing mortality after LPS challenge, and enhanced the survival of mice subjected to peritonitis induced by gram-positive or -negative bacteria or to polymicrobial peritoneal sepsis triggered by colon ascendens stent implantation. Thus, APC's efficacy in severe sepsis is predominantly based on EPCR- and PAR1-dependent cell signaling, and APC variants with normal cell signaling but reduced anticoagulant activities retain efficacy while reducing the risk of bleeding.
Abbreviations used: 7-AAD, 7-amino-actinomycin D; APC, activated protein C; CASP, colon ascendens stent peritonitis; EPCR, endothelial cell protein C receptor; MPO, myeloperoxidase; MW, molecular weight; PAR1, protease-activated receptor 1; TAT, thrombin–antithrombin complex; TUNEL, Tdt-mediated dUTP-biotin nick-end labeling.
J.H. Griffin and H. Weiler contributed equally to this work.
N. Mackman's present address is Dept. of Medicine, University of North Carolina, Chapel Hill, NC 27599.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Improving survival after sepsis
- Hema Bashyam
J. Exp. Med. 2007 204: 2242.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Sennoun, N., Baron-Menguy, C., Burban, M., Lecompte, T., Andriantsitohaina, R., Henrion, D., Mercat, A., Asfar, P., Levy, B., Meziani, F.
(2009). Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries. Am. J. Physiol. Heart Circ. Physiol.
297: H277-H282
[Abstract]
[Full Text]
-
Di Cera, E.
(2009). Know your APC. Blood
113: 5699-5700
[Full Text]
-
Mosnier, L. O., Zampolli, A., Kerschen, E. J., Schuepbach, R. A., Banerjee, Y., Fernandez, J. A., Yang, X. V., Riewald, M., Weiler, H., Ruggeri, Z. M., Griffin, J. H.
(2009). Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood
113: 5970-5978
[Abstract]
[Full Text]
-
Wang, Y., Thiyagarajan, M., Chow, N., Singh, I., Guo, H., Davis, T. P., Zlokovic, B. V.
(2009). Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity. Stroke
40: 1864-1869
[Abstract]
[Full Text]
-
Elphick, G. F., Sarangi, P. P., Hyun, Y.-M., Hollenbaugh, J. A., Ayala, A., Biffl, W. L., Chung, H.-L., Rezaie, A. R., McGrath, J. L., Topham, D. J., Reichner, J. S., Kim, M.
(2009). Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood
113: 4078-4085
[Abstract]
[Full Text]
-
Niessen, F., Furlan-Freguia, C., Fernandez, J. A., Mosnier, L. O., Castellino, F. J., Weiler, H., Rosen, H., Griffin, J. H., Ruf, W.
(2009). Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood
113: 2859-2866
[Abstract]
[Full Text]
-
Preston, R. J. S., Tran, S., Johnson, J. A., Ainle, F. N., Harmon, S., White, B., Smith, O. P., Jenkins, P. V., Dahlback, B., O'Donnell, J. S.
(2009). Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C. J. Biol. Chem.
284: 5869-5875
[Abstract]
[Full Text]
-
Gupta, A., Gerlitz, B., Richardson, M. A., Bull, C., Berg, D. T., Syed, S., Galbreath, E. J., Swanson, B. A., Jones, B. E., Grinnell, B. W.
(2009). Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury. J. Am. Soc. Nephrol.
20: 267-277
[Abstract]
[Full Text]
-
Looney, M R, Esmon, C T, Matthay, M A
(2009). Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury. Thorax
64: 114-120
[Abstract]
[Full Text]
-
Mullins, E. S., Kombrinck, K. W., Talmage, K. E., Shaw, M. A., Witte, D. P., Ullman, J. M., Degen, S. J., Sun, W., Flick, M. J., Degen, J. L.
(2009). Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain. Blood
113: 696-704
[Abstract]
[Full Text]
-
Yang, X. V., Banerjee, Y., Fernandez, J. A., Deguchi, H., Xu, X., Mosnier, L. O., Urbanus, Rolf. T., de Groot, P. G., White-Adams, T. C., McCarty, O. J. T., Griffin, J. H.
(2009). Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc. Natl. Acad. Sci. USA
106: 274-279
[Abstract]
[Full Text]
-
Schulteis, R. D., Chu, H., Dai, X., Chen, Y., Edwards, B., Haribhai, D., Williams, C. B., Malarkannan, S., Hessner, M. J., Glisic-Milosavljevic, S., Jana, S., Kerschen, E. J., Ghosh, S., Wang, D., Kwitek, A. E., Lernmark, A., Gorski, J., Weiler, H.
(2008). Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood
112: 4905-4914
[Abstract]
[Full Text]
-
Harmon, S., Preston, R. J. S., Ainle, F. N., Johnson, J. A., Cunningham, M. S., Smith, O. P., White, B., O'Donnell, J. S.
(2008). Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement. J. Biol. Chem.
283: 30531-30539
[Abstract]
[Full Text]
-
Tauseef, M., Kini, V., Knezevic, N., Brannan, M., Ramchandaran, R., Fyrst, H., Saba, J., Vogel, S. M., Malik, A. B., Mehta, D.
(2008). Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells. Circ. Res.
103: 1164-1172
[Abstract]
[Full Text]
-
Sood, R., Sholl, L., Isermann, B., Zogg, M., Coughlin, S. R., Weiler, H.
(2008). Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood
112: 585-591
[Abstract]
[Full Text]
-
Gilbert, R. E., Marsden, P. A.
(2008). Activated Protein C and Diabetic Nephropathy. NEJM
358: 1628-1630
[Full Text]
-
Richardson, M. A., Gupta, A., O'Brien, L. A., Berg, D. T., Gerlitz, B., Syed, S., Sharma, G. R., Cramer, M. S., Heuer, J. G., Galbreath, E. J., Grinnell, B. W.
(2008). Treatment of Sepsis-Induced Acquired Protein C Deficiency Reverses Angiotensin-Converting Enzyme-2 Inhibition and Decreases Pulmonary Inflammatory Response. J. Pharmacol. Exp. Ther.
325: 17-26
[Abstract]
[Full Text]
-
Schuepbach, R. A., Feistritzer, C., Brass, L. F., Riewald, M.
(2008). Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood
111: 2667-2673
[Abstract]
[Full Text]
-
Riewald, M., Schuepbach, R. A.
(2008). Protective Signaling Pathways of Activated Protein C in Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
28: 1-3
[Full Text]